Rosenthal J D, Hayashi K, Notkins A L
Appl Microbiol. 1973 Apr;25(4):567-73. doi: 10.1128/am.25.4.567-573.1973.
Viral antigens were fixed to the surface of microtiter wells, and serial dilutions of antiviral antibody were added. The amount of antiviral antibody bound to viral antigens was determined by measuring the extent to which the antiviral antibody either inhibited the specific binding of (125)I-labeled antiviral immunoglobulin G (IgG) (direct technique) or enhanced the specific binding of (125)I-labeled anti-IgG (indirect technique). Immune complexes composed of viral antigens and antiviral antibody (human) could be detected by the binding of (125)I-labeled rheumatoid factor. Specific binding was influenced by the concentration of protein in the diluents used during the different steps of the procedure. A high concentration of protein in the diluent used with the viral antigens decreased specific binding, whereas a high concentration of protein in the diluent used with (125)I-labeled anti-IgG increased specific binding by decreasing nonspecific attachment of the labeled anti-IgG. Under the conditions employed, the titer of a given antiviral serum was several hundredfold greater by the indirect than by the direct technique.
将病毒抗原固定在微量滴定板孔的表面,然后加入抗病毒抗体的系列稀释液。通过测量抗病毒抗体抑制(125)I标记的抗病毒免疫球蛋白G(IgG)的特异性结合(直接技术)或增强(125)I标记的抗IgG的特异性结合(间接技术)的程度,来确定与病毒抗原结合的抗病毒抗体的量。由病毒抗原和抗病毒抗体(人)组成的免疫复合物可通过(125)I标记的类风湿因子的结合来检测。特异性结合受该程序不同步骤中所用稀释剂中蛋白质浓度的影响。与病毒抗原一起使用的稀释剂中高浓度的蛋白质会降低特异性结合,而与(125)I标记的抗IgG一起使用的稀释剂中高浓度的蛋白质会通过减少标记抗IgG的非特异性附着而增加特异性结合。在所采用的条件下,给定抗病毒血清的效价通过间接技术比直接技术高数百倍。